Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
Int J Cardiol. 2013 Nov 20;169(5):317-26. doi: 10.1016/j.ijcard.2013.09.001. Epub 2013 Sep 6.
To systematically assess the current clinical evidence of acupuncture for hypertension.
The PubMed, EMBASE, Chinese Biomedical Literature Database (CBM), Chinese National Knowledge Infrastructure (CNKI), Chinese Scientific Journal Database (VIP), and Wan-fang Data in the Cochrane Library were searched until January, 2013. All the randomized controlled trials (RCTs) based on acupuncture compared with western medicine, sham acupuncture or lifestyle intervention in patients with hypertension were included. RCTs were included as well as combined acupuncture with western medicine compared with western medicine. In addition, RCTs based on acupuncture compared with sham acupuncture combined with western medicine in patients with essential hypertension were included. No language restriction was used. Review Manager 5.1 software was used for data analysis. Study selection, data extraction, quality assessment, and data analyses were conducted according to the Cochrane standards.
35 randomized trials (involving 2539 patients) were included. The methodological quality of the included trials was evaluated as generally low. Two trials reported the effect of acupuncture compared with sham acupuncture in combinations of western medicine. Acupuncture significantly reduced SBP (-7.47 mmHg, 95% CI - 10.43 to -4.5, P<0.00001) and DBP (-4.22 mmHg, 95% CI - 6.26 to -2.18, P<0.0001) and no heterogeneity between studies was detected. However, other studies had substantial heterogeneity due to the quality of them was poor, and their sample sizes were not satisfactory as an equivalence study. Five trials described the adverse effects.
While there are some evidences that suggest potential effectiveness of acupuncture for hypertension, the results were limited by the methodological flaws of the studies. Therefore, further thorough investigation, large-scale, proper study designed, randomized trials of acupuncture for hypertension will be required to justify the effects reported here.
系统评价针灸治疗高血压的临床证据。
检索 Cochrane 图书馆中的 PubMed、EMBASE、中国生物医学文献数据库(CBM)、中国知网(CNKI)、中国科技期刊数据库(VIP)和万方数据,检索时间截至 2013 年 1 月。纳入所有针灸与西药、假针灸或生活方式干预治疗高血压患者的随机对照试验(RCT)。包括单纯针灸与西药的 RCT,以及针灸与西药联合的 RCT。此外,纳入针灸与假针灸联合西药治疗原发性高血压患者的 RCT。未对语言进行限制。采用 Review Manager 5.1 软件进行数据分析。根据 Cochrane 标准进行研究选择、数据提取、质量评估和数据分析。
纳入 35 项 RCT(涉及 2539 例患者)。纳入研究的方法学质量普遍较低。有 2 项研究报道了针灸与假针灸联合西药的疗效。针灸显著降低收缩压(-7.47mmHg,95%CI-10.43 至-4.5,P<0.00001)和舒张压(-4.22mmHg,95%CI-6.26 至-2.18,P<0.0001),且研究间无异质性。但是,由于其他研究的质量较差,样本量也不满意,因此存在较大的异质性。有 5 项研究描述了不良反应。
虽然有一些证据表明针灸治疗高血压可能有效,但这些结果受到研究方法学缺陷的限制。因此,需要进一步进行彻底的调查、大规模、设计合理、随机对照试验来验证这里报道的疗效。